What is the current Metformin API market size?

The Metformin API market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Metformin API market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Metformin API market?

Increasing demand for diabetes treatment and growing generic drug market drive the Metformin API market.

What are the major challenges facing the Metformin API market?

Stringent regulatory requirements and intense competition are major challenges for the Metformin API market.

Which regions are the leaders in the Metformin API market?

North America and Europe are the leading regions in the Metformin API market.

Who are the top companies in the Metformin API market?

Top companies include Mylan, Teva, and Sandoz, which dominate the Metformin API market.

What are the future opportunities in the Metformin API market?

Growing demand in emerging economies and increasing use in polycystic ovary syndrome treatment offer future opportunities.

How will technology impact the Metformin API market?

Advancements in manufacturing technology will improve efficiency and reduce costs in the Metformin API market.

What is the current regulatory landscape for the Metformin API market?

The Metformin API market is regulated by authorities such as FDA and EMA, ensuring quality and safety standards.

What is the future outlook for the Metformin API market?

The future outlook is positive, with growing demand and increasing use in various applications.

Metformin API Strategic Analysis & Growth Outlook 2033

Metformin API by Application (Tablet, Capsule), by Types (99% or More, Less than 99%), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Metformin API Market Overview

The Metformin API market refers to the global market for the active pharmaceutical ingredient (API) Metformin, which is used to treat type 2 diabetes. As the Metformin API market size continues to grow, it is essential to understand the growth outlook, market forecast, and industry expansion. The scope of this market encompasses the production, distribution, and consumption of Metformin API, with a focus on pharmaceutical manufacturing, API supply chain, and regulatory compliance. The current Metformin API market size is approximately $1.3 billion, with a expected growth rate of 5-7% per annum. The growth forecast indicates a positive trend, driven by increasing demand for Metformin in the treatment of type 2 diabetes, with a compound annual growth rate (CAGR) of around 6% during the forecast period.

Loading chart…

The Metformin API market is shaped by several key forces, including technology shifts in pharmaceutical manufacturing, regulatory compliance with evolving quality standards, and competitive intensity among API suppliers. The largest region for Metformin API consumption is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing demand for diabetes treatment in countries such as China and India. As the pharmaceutical industry continues to evolve, understanding the Metformin API market is crucial for strategic planners, business development teams, and C-suite executives seeking to navigate the complex landscape of pharmaceutical manufacturing and API supply chain management.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.03 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Wanbury; USV; Shouguang Fukang Pharmaceutical; Vistin Pharma; Keyuan Pharmaceutical; Farmhispania Group; Harman Finochem; Shijiazhuang Polee Pharmaceutical; Aarti Drugs; Exemed Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Metformin API market is poised for significant growth, driven by increasing demand for antidiabetic medications and advancements in pharmaceutical manufacturing technologies. The Metformin API market size is expected to expand substantially over the forecast period, with a promising growth forecast that underscores the importance of this therapeutic agent in the treatment of type 2 diabetes.

Growth Drivers2 items

Rising prevalence of type 2 diabetes and the associated need for effective, affordable treatments are driving the demand for Metformin API, thereby contributing to the growth of the Metformin API market.

Advancements in production technologies and the emergence of new manufacturing facilities are enhancing the supply of high-quality Metformin API, further boosting the growth forecast of the market.

Restraints2 items

Stringent regulatory requirements and quality control measures imposed by authorities such as the FDA and EMA can limit the entry of new players into the Metformin API market, potentially hindering its growth.

Fluctuations in the prices of raw materials and energy costs can impact the profitability of Metformin API manufacturers, affecting the overall Metformin API market size.

Opportunities2 items

Growing demand from emerging economies, where diabetes prevalence is increasing rapidly, presents a significant opportunity for Metformin API manufacturers to expand their market reach and contribute to the growth forecast.

The development of novel formulations and combination therapies using Metformin API can offer new revenue streams for pharmaceutical companies and further enhance the Metformin API market size.

Challenges2 items

Ensuring the quality consistency of Metformin API across different manufacturing sites and batches remains a challenge for suppliers, affecting the reliability of the Metformin API market.

The Metformin API market is highly competitive, with several established players, which can make it difficult for new entrants to gain significant market share and impact the overall growth forecast.

Market Segmentation

Loading chart…

The Metformin API market can be segmented based on Application, which refers to the various uses of Metformin API in the pharmaceutical industry. This segment contributes significantly to the overall Metformin API market size, as different applications have distinct requirements and demand patterns. The Metformin API segmentation by application includes type 2 diabetes, polycystic ovary syndrome (PCOS), and other applications, each with its own set of characteristics and market dynamics.

Another crucial aspect of Metformin API market taxonomy is the Types segment, which encompasses various subtypes such as [object Object] and [object Object]. This segment is vital in understanding the market's overall structure, as different types of Metformin API cater to specific needs and have varying market shares. The market taxonomy of Metformin API types reveals the complex interplay between supply and demand, driving growth and innovation in the industry.

Metformin API Segmentation Breakdown6 items

Application

Tablet

Capsule

Types

99% or More

Less than 99%

Regional Insights

Loading chart…

The Metformin API market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, driven by high adoption rates, government policies, and increasing investments in the pharmaceutical industry. The fastest-growing region is anticipated to be Latin America, driven by expanding demographics, improving infrastructure, and maturing ecosystem.

In North America, key drivers include established infrastructure, high demand for Metformin, and favorable regulatory policies. Europe is driven by strong research and development, high per capita income, and increasing awareness about diabetes treatment. Asia Pacific's growth is further fueled by low-cost manufacturing, large patient population, and growing healthcare expenditure. Latin America's growth is driven by rising healthcare awareness, increasing access to healthcare services, and growing economies. The Middle East & Africa region is driven by growing demand for Metformin, expanding healthcare infrastructure, and increasing investments in the pharmaceutical sector.

The regional forecast indicates that the Metformin API market will continue to grow, driven by increasing demand for diabetes treatment and advancements in pharmaceutical technology. As the market evolves, it is essential to monitor the Metformin API market growth and trends in each region to capitalize on emerging opportunities.

Competitive Landscape

The Metformin API market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Metformin API competitive landscape is characterized by high competition, with key players employing various strategies to differentiate themselves. Global players tend to focus on product innovation and regulatory approvals, while local companies often prioritize pricing and distribution.

Companies in the Metformin API market employ common strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. However, they face challenges like margin pressure, compliance costs, and commoditization, which can impact their bottom line. To differentiate themselves, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Wanbury: regional expansion

USV: vertical integration

Shouguang Fukang Pharmaceutical: premium pricing

Vistin Pharma: OEM tie-ups

Keyuan Pharmaceutical: innovation pipeline

Farmhispania Group: local manufacturing

Key Metformin API Companies10 items

Wanbury

USV

Shouguang Fukang Pharmaceutical

Vistin Pharma

Keyuan Pharmaceutical

Farmhispania Group

Harman Finochem

Shijiazhuang Polee Pharmaceutical

Aarti Drugs

Exemed Pharmaceuticals

Market Ecosystem

The Metformin API ecosystem encompasses a complex network of participants, from upstream raw material suppliers to downstream end users, with value created and captured at various stages. The ecosystem can be broadly segmented into three main categories: upstream technology providers and suppliers, midstream integrators and manufacturers, and downstream channels and end users. Understanding the Metformin API ecosystem requires a thorough value chain analysis to identify key participants, their roles, and interactions.

Raw material suppliers — provide active pharmaceutical ingredients

Technology providers — develop manufacturing processes and technologies

OEMs / manufacturers — produce Metformin API

System integrators / EPCs — integrate API into formulations

Distributors / channel partners — distribute API to pharmaceutical companies

Regulators/standards bodies — set quality and safety standards

End users / buyers — pharmaceutical companies and formulators

In the Metformin API ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through quality and safety standards. Dependency risks arise from input constraints, such as raw material availability, and approvals from regulatory bodies. Switching costs are relatively high due to stringent quality requirements and limited substitutability of Metformin API. The ecosystem's structure and dynamics may differ by region, with varying regulatory requirements and market conditions affecting the flow of value and the interactions among participants.

Recent Industry Insights

The Metformin API industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing manufacturing capabilities and expanding distribution networks. Notable mergers and acquisitions have also taken place, aiming to consolidate market share and improve competitiveness. Furthermore, several companies have launched new products and technologies, including more efficient synthesis methods and improved formulation techniques.

In addition to these advancements, regulatory changes have played a crucial role in shaping the Metformin API market. Shifts in consumer and enterprise trends have led to increased demand for high-quality, affordable Metformin API. Funding rounds and expansions have also been observed, with companies investing in research and development to stay ahead of the curve and capitalize on emerging opportunities in the Metformin API industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Metformin API market outlook. The market attractiveness is moderate, driven by increasing demand for metformin in the treatment of type 2 diabetes. Competitive intensity is high, with several established players and new entrants vying for market share.

The long-term outlook for the Metformin API market is positive, with growth opportunities in emerging markets and the potential for innovative formulations. However, the market is not without risks, including fluctuations in raw material prices and regulatory challenges. Demand-supply balance is expected to be stable, with manufacturers adjusting production to meet growing demand. Key risk factors include quality control issues and supply chain disruptions.

12 items

1. Executive Summary

2. Metformin API Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Metformin API Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Metformin API Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Metformin API Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Metformin API Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Metformin API Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Metformin API Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Metformin API Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Metformin API Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Metformin API Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Metformin API Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Metformin API Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Metformin API Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Metformin API Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Metformin API Market Competition by Key Manufacturers

9.1. Global Metformin API Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Metformin API: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Wanbury

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. USV

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Shouguang Fukang Pharmaceutical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Vistin Pharma

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Keyuan Pharmaceutical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Farmhispania Group

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Harman Finochem

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Shijiazhuang Polee Pharmaceutical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Aarti Drugs

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Exemed Pharmaceuticals

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Metformin API Market

Figure 4: Global Metformin API Market: Drivers

Figure 5: Global Metformin API Market: Challenges

Figure 6: Global Metformin API Market: Trends

Figure 7: Global Metformin API Market: Opportunity

Figure 8: Global Metformin API Market: Restraint

Figure 9: Global Metformin API Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Metformin API Market Value (USD Million) By Region

Figure 19: Global Metformin API Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Metformin API Market Value (USD Million) By Region

Figure 27: Global Metformin API Market Share (%) By: Regions (2032)

Figure 28: Global Metformin API Market Volume (K) By Region

Figure 29: Global Metformin API Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Metformin API Market Value (USD Million) By Region

Figure 37: Global Metformin API Market Share (%) By: Regions (2032)

Figure 38: Global Metformin API Market Volume (K) By Region

Figure 39: Global Metformin API Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Metformin API Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Metformin API Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Metformin API Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Metformin API Market Value (USD Million) By Region

Table 14: Global Metformin API Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Metformin API Market Volume (K) By Region

Table 31: Global Metformin API Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Metformin API Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Metformin API Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Metformin API Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Wanbury Basic Information And Sales Area

Table 52: Wanbury. Products Portfolio

Table 53: USV Basic Information And Sales Area

Table 54: USV. Products Portfolio

Table 55: Shouguang Fukang Pharmaceutical Basic Information And Sales Area

Table 56: Shouguang Fukang Pharmaceutical. Products Portfolio

Table 57: Vistin Pharma Basic Information And Sales Area

Table 58: Vistin Pharma. Products Portfolio

Table 59: Keyuan Pharmaceutical Basic Information And Sales Area

Table 60: Keyuan Pharmaceutical. Products Portfolio

Table 61: Farmhispania Group Basic Information And Sales Area

Table 62: Farmhispania Group. Products Portfolio

Table 63: Harman Finochem Basic Information And Sales Area

Table 64: Harman Finochem. Products Portfolio

Table 65: Shijiazhuang Polee Pharmaceutical Basic Information And Sales Area

Table 66: Shijiazhuang Polee Pharmaceutical. Products Portfolio

Table 67: Aarti Drugs Basic Information And Sales Area

Table 68: Aarti Drugs. Products Portfolio

Table 69: Exemed Pharmaceuticals Basic Information And Sales Area

Table 70: Exemed Pharmaceuticals. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Metformin API Market Value (USD Million) By Region

Table 80: Global Metformin API Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Metformin API Market Volume (K) By Region

Table 97: Global Metformin API Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Metformin API Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.03 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Wanbury; USV; Shouguang Fukang Pharmaceutical; Vistin Pharma; Keyuan Pharmaceutical; Farmhispania Group; Harman Finochem; Shijiazhuang Polee Pharmaceutical; Aarti Drugs; Exemed Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Fluctuations in the prices of raw materials and energy costs can impact the profitability of Metformin API manufacturers, affecting the overall Metformin API market size.

Opportunities2 items

The development of novel formulations and combination therapies using Metformin API can offer new revenue streams for pharmaceutical companies and further enhance the Metformin API market size.

Challenges2 items

Ensuring the quality consistency of Metformin API across different manufacturing sites and batches remains a challenge for suppliers, affecting the reliability of the Metformin API market.

Market Segmentation

Loading chart…

Metformin API Segmentation Breakdown6 items

Application

Tablet

Capsule

Types

99% or More

Less than 99%

Regional Insights

Loading chart…

Competitive Landscape

Wanbury: regional expansion

USV: vertical integration

Shouguang Fukang Pharmaceutical: premium pricing

Vistin Pharma: OEM tie-ups

Keyuan Pharmaceutical: innovation pipeline

Farmhispania Group: local manufacturing

Key Metformin API Companies10 items

Wanbury

USV

Shouguang Fukang Pharmaceutical

Vistin Pharma

Keyuan Pharmaceutical

Farmhispania Group

Harman Finochem

Shijiazhuang Polee Pharmaceutical

Aarti Drugs

Exemed Pharmaceuticals

Market Ecosystem

Raw material suppliers — provide active pharmaceutical ingredients

Technology providers — develop manufacturing processes and technologies

OEMs / manufacturers — produce Metformin API

System integrators / EPCs — integrate API into formulations

Distributors / channel partners — distribute API to pharmaceutical companies

Regulators/standards bodies — set quality and safety standards

End users / buyers — pharmaceutical companies and formulators

Recent Industry Insights

Analyst Overview

Table of Contents